Home >> Investor Relations
Investor Relations          
 

Investor Relations

   Stock Information
   Ownership Structure
   Financial Reports
   Regulatory Filings
Investor Relations
 
Home
 

 Recent Financial Reports

30 November 2009
Board of Directors Report - 3rd Quarter 2009
Auditor's Report - 3rd Quarter 2009
 
26 November 2009
Shelf Prospectus
 
View all financial reports

 

         

 Recent Investor Presentations

18 February 2010
BiondVax - Corporate Presentation, February 2010
 
 
 
 
 

 

 Recent News

8 March 2010
BiondVax Reports Positive Interim Safety Results from Second Phase I/II Universal Influenza Vaccine Trial
 
24 February 2010
BiondVax signs Term Sheet for up to $7m through a 3 year Standby Equity Distribution Agreement (SEDA) with Yorkville Advisor
 
9 December 2009
Successful Stock Offering
 
7 December 2009
Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals’ Universal Flu Vaccine
 
View all news stories

 

   

 Recent Events

Tel Aviv Stock Exchange - BioMed Conference
7 December 2009, Tel Aviv, Israel
 
World Influenza Congress, Europe 2009
8 December 2009, Brussels, Belgium
 
 
 
 

 


Go Back  Print  Send Page

BiondVax Pharmaceuticals Ltd.
Science Park, 14 Einstein Street

PO Box 4143

Ness Ziona, 74140, Israel

© BiondVax Pharmaceuticals Ltd, 2007 - 2010 All rights reserved  l   Disclaimer Email:  info@biondvax.com
Phone:  +972 8 930 2529
Fax:  +972 8 930 2531
Add to Favorites           Make Us Your Home Page           Site Map